Company

Novartis

2022

Quick facts

9,272,100

Emissions (ton CO₂e)

50,950

Revenue (M USD)

181.98

Intensity (t CO₂e / M USD)

Ambition & Development

In 2022, Novartis reported a total of 9,272,100 ton CO₂e, and a net revenue of 50,950 M USD, resulting in a emissions intensity of 181.98 t CO₂e / M USD.

Targets

Base year:

2016

Target year:

2030

Reduction:

0.35

Classification:

Well-below 2°C

Swiss multinational pharmaceutical company Novartis commits to reduce absolute scope 1, 2 and 3 GHG emissions 35% by 2030 from a 2016 base-year.

Source: Science Based Target initative

Emissions, Revenue & Intensity

Emissions, Target & Trend

Revenue	2020	2021	2022
Net Revenue (M USD)	48,600	51,630	50,950
Revenue Source

Emissions Overview	2020	2021	2022
Total Emissions - Market Based (t CO₂e)
Emissions Intensity (t CO₂e / M USD)	16.78	153.71	181.98
Cradle-to-gate Intensity (t CO₂e / M USD)	16.78	153.71	181.98

Emissions Details	2020	2021	2022
Scope 1	396,400	352,800	347,200
Scope 2
Scope 2 - Location Based
Scope 2 - Market Based
Scope 2 - Not specified	392,200	292,700	154,900
Scope 3	27,000	7,290,400	8,770,000
Upstream Emissions
1. Purchased goods and services
2. Capital goods
3. Fuel- and energy-related activities
4. Upstream transportation and distribution
5. Waste generated in operations
6. Business travel
7. Employee commuting
8. Upstream leased assets
Downstream Emissions
9. Downstream transportation and distribution
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions	815,600	7,935,900	9,272,100
Emission Source

Open Sustainability Index

Licensed under CC BY-SA 4.0